Market Research Future has added a report titled “Orthopedic Biomaterial Market Research-
Asia Pacific Forecast Till 2023” to its offering. The report provides an in-depth analysis of
regional data and an accurate projection of the market size and share of the Top 10 market
players across the globe.
Market Scenario
orthopedic biomaterials are organic or synthetic materials used for the treatment of internal
fractures. During the last decade different new techniques and materials are introduced for
orthopedic implants and surgeries and biomaterials have found a vital role in it. These
biomaterials are used in manufacturing of different implants since they do not evoke any
immunological reactions with the body, which makes it a first choice for manufacturing of
implants. Increasing demand for the orthopedic biomaterial because of its application in
knee and hip replacement surgeries, and increasing incident of medical emergencies drive
the Asia Pacific orthopedic biomaterial market. Introduction of novel implants of titanium
has increased the success rate of implant surgeries and also contributed to the growth of
the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries,
increasing aging population, and growing governmental support also drive the Asia Pacific
market. However, increasing failure in joints implants, stringent regulatory laws, and high
cost of treatment may hinder the growth of market during the review period.
The Asia Pacific orthopedic biomaterial market is expected to grow at a CAGR of 12.6%
during the forecasted period 2017-2023.
Get Premium Sample Copy @
https://www.marketresearchfuture.com/sample_request/643
Key Players
Some of the major players in this market: Kyocera Corporation (Japan), Materion
Corporation (US), S&V Technologies (Germany), Rayner (UK), InVision Biomedical
(US), Covestro (Germany), Invibio Ltd. (U.K.), Royal DSM (Netherlands), BASF SE
(Germany), Corbion N.V. (Netherlands), CeramTec (Germany), Tianjin Walkman Biomaterial
Co. (China), Kanghui Holdings (China), Johnson & Johnson Services, Inc. (US), Cam
Bioceramics B.V. (Netherland), and Xian Airfoil Technology Co (China).
Segmentation
The global orthopedic biomaterials market is segmented on the basis of types of material,
applications, and end users. On the basis of types of material, the market is segmented into
metals and non-metals. The metals are further segmented into stainless steel, titanium
alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric,
natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium
phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-